Stocks
Boston Scientific (BSX) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 4.83 | 4.26 | 2.70 | 2.98 | 2.38 | 2.40 | |||
| Changes by years, y/y, % | +70% | -12% | -37% | +10% | -20% | -3.5% | |||
Boston Scientific. Debt/EBITDA
Boston Scientific. Debt/EBITDA, changes, %
Boston Scientific (BSX) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| Debt/EBITDA | 3.04 | 3.02 | 2.67 | 2.57 | 2.40 | 2.40 | ||
| Changes by years, y/y, % | -15% | -17% | -18% | +6% | -21% | |||
| Changes by quarters, q/q, % | +25% | 0% | -12% | -4% | -7% | |||
